FR2725133B1 - Composition pharmaceutique de fantofarone pour administration orale - Google Patents

Composition pharmaceutique de fantofarone pour administration orale

Info

Publication number
FR2725133B1
FR2725133B1 FR9411755A FR9411755A FR2725133B1 FR 2725133 B1 FR2725133 B1 FR 2725133B1 FR 9411755 A FR9411755 A FR 9411755A FR 9411755 A FR9411755 A FR 9411755A FR 2725133 B1 FR2725133 B1 FR 2725133B1
Authority
FR
France
Prior art keywords
fantofarone
pharmaceutical composition
oral administration
oral
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9411755A
Other languages
English (en)
Other versions
FR2725133A1 (fr
Inventor
Bernard Abramovici
Jean Claude Gautier
Jean Claude Gromenil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Priority to FR9411755A priority Critical patent/FR2725133B1/fr
Priority to AU35701/95A priority patent/AU3570195A/en
Priority to PCT/FR1995/001245 priority patent/WO1996010406A1/fr
Publication of FR2725133A1 publication Critical patent/FR2725133A1/fr
Application granted granted Critical
Publication of FR2725133B1 publication Critical patent/FR2725133B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
FR9411755A 1994-09-30 1994-09-30 Composition pharmaceutique de fantofarone pour administration orale Expired - Fee Related FR2725133B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9411755A FR2725133B1 (fr) 1994-09-30 1994-09-30 Composition pharmaceutique de fantofarone pour administration orale
AU35701/95A AU3570195A (en) 1994-09-30 1995-09-27 Pharmaceutical composition of fantofarone for oral administration
PCT/FR1995/001245 WO1996010406A1 (fr) 1994-09-30 1995-09-27 Composition pharmaceutique de fantofarone pour administration orale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9411755A FR2725133B1 (fr) 1994-09-30 1994-09-30 Composition pharmaceutique de fantofarone pour administration orale

Publications (2)

Publication Number Publication Date
FR2725133A1 FR2725133A1 (fr) 1996-04-05
FR2725133B1 true FR2725133B1 (fr) 1996-12-20

Family

ID=9467485

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9411755A Expired - Fee Related FR2725133B1 (fr) 1994-09-30 1994-09-30 Composition pharmaceutique de fantofarone pour administration orale

Country Status (3)

Country Link
AU (1) AU3570195A (fr)
FR (1) FR2725133B1 (fr)
WO (1) WO1996010406A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57140713A (en) * 1981-02-25 1982-08-31 Nippon Chemiphar Co Ltd Novel preventing agent and remedy for allergic disease
FR2594438B1 (fr) * 1986-02-14 1990-01-26 Labaz Sanofi Nv Derives d'indolizine, leur procede de preparation ainsi que les compositions en contenant
IL87181A (en) * 1987-08-07 1993-08-18 Sanofi Sa Aminoalkoxyphenyl derivatives, their preparation and pharmaceutical and veterinary compositions containing them

Also Published As

Publication number Publication date
FR2725133A1 (fr) 1996-04-05
WO1996010406A1 (fr) 1996-04-11
AU3570195A (en) 1996-04-26

Similar Documents

Publication Publication Date Title
FR2732223B1 (fr) Composition pharmaceutique pour administration transdermique
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
DZ1876A1 (fr) Médicaments pour administration orale.
FR2761265B1 (fr) Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
DZ1077A1 (fr) Nouvelles préparation pharmaceutique pour administration orale.
EE03177B1 (et) Heterobitsüklilised ühendid, nende saamismeetod ja nimetatud ühendeid sisaldavad farmatseutilised kompositsioonid
DE69634053D1 (de) Oral anzuwendende Arzneizusammensetzung enthaltend 2-Methyl-thienobenzodiazepin
DZ2453A1 (fr) Composition pharmaceutique pour administration orale d'un dérivé du n-pipéndin-3-pyrazolecarboxamidede ses sels et de leurs solvates.
DZ2494A1 (fr) Composition pharmaceutique d'oméprazole.
FI972945A (fi) Antigeenien antamiseen soveltuvia koostumuksia
PT892640E (pt) Composicoes farmaceuticas de micofenolato entericamente revestidas
HU9502520D0 (en) Pharmaceutical use of substituted 4-phenyl-6-amino-nicotinic acid derivatives
FR2754177B1 (fr) Microspheres pharmaceutiques d'acide valproique pour administration orale
FI970331A (fi) Lääkkeen antokoostumus virustenvastaisten aineiden nenään toteutettavaa antoa varten
PT835103E (pt) Nanoparticulas para administracao oral de agentes farmaceuticos de baixa solubilidade
NO950134D0 (no) Formuleringer for oralt administrerte farmasöytiske midler
BE890796A (fr) Composition pharmaceutique pour administration par voie orale contenant de la cytidine-diphosphocholine
FR2748394B1 (fr) Applicateur de medicaments pour animaux
MA23663A1 (fr) Procede de preparation de formulations pharmaceutiques
NO961797D0 (no) Anvendelse av benzopyranderivater for fremstilling av farmasöytiske sammensetninger beregnet for behandling av patologier forbundet med den Na+-uavhengige C1-HCO3-utbytter
DK0831820T3 (da) Oral farmaceutisk sammensætning af piperidinoalkanolforbindelser på opløsningsform
FR2725133B1 (fr) Composition pharmaceutique de fantofarone pour administration orale
BR9307182A (pt) Composições farmacêuticas de 2-oxindol-1-carboxamidas 3-substituídas
FR2732896B1 (fr) Forme pharmaceutique transdermique pour l'administration percutanee de l'apomorphine
FR2702960B1 (fr) Leurre pour l'administration orale de médicaments vétérinaires.

Legal Events

Date Code Title Description
ST Notification of lapse